Reed Jobs would rather talk about curing cancer than his last name

When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs's words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.

from TechCrunch https://ift.tt/bN5twXm
via IFTTT

Comments

Popular posts from this blog

Google signs Stephen Curry to pitch its Pixel, health, and AI gear

Libby introduces ‘Inspire Me’ to beef up your reading list

Google is supercharging screenshot editing on your Pixel with Android 16 QPR2 Beta 1